Thursday, February 13, 2014

2/13/2014 Comcast JUMPS the GUN, and BUYS TIME-WARNER CABLE, what a heck of a play for Comcast, L.A. & NEW York will finally be offered true high definition home-entertainment by a cable company that actually cares about its consumers! Stock quote CMCSA (Comcast) with a $69.00 target!

Long COMCAST CORPORATION (CMCSA)

                    $69.00 12 Month Price Target

COMCAST INCREASES DIVIDEND AND SHARE REPURCHASES
Dividend to Increase 15.4% to $0.90 per Share on an Annualized Basis Share Repurchase Authorization to Increase to $7.5 Billion, with $3.0 Billion to be Repurchased in 2014 PHILADELPHIA--(BUSINESS WIRE)-- Comcast Corporation (NASDAQ...http://www.cmcsa.com/releasedetail.cfm?ReleaseID=821444
         This is a great move for Comcast Cable and the Tri-state are as well as L.A. You see Time Warner had been well behind Cablevision and Comcast as far as updating their copper infrastructure. Both, Comcast and Cablevision, have diligently been updating their network to compete with Verizon FIos, they bring fiber to the node. You see a node, predominantly, entangles 30 units in its web, by bringing fiber to the node this enables the copper companies to increase bandwidth, and thus deliver more channels and faster internet service. Comcast has also been very keen in even adding boosters to the copper lines that connect from the node to a unit and/or house, and they had been able to deliver a true 20/5 speed of internet with their basic residential package. Now 20/5 isn't truly light speed fiber-optic internet like a 50/20 speed that which FIos brings to the table, but it's definitely fast enough to compete as the residential consumer is reluctant to even notice the difference. 
            You see Time Warner had been lacking in the internet department for quite some time, as far as what speed of internet they could bring to the table. Their drag of a network could barely deliver 10/2. Now, this has all been due to the fact that Time Warner had become lazy, and for quite some time they had not been working on updating their infrastructure. 
           I knew for awhile now that,most likely, Time Warner would either sell, or be bought out, due to the fact that you could tell that ownership had abandoned the product, rather than put in the work to keep up with competition, TW was work-shy, they thought for some time they could compete and get away by just spending millions in bolstered commercial advertisement campaigns, but over time the masses began to see through this fa-sad, spending money only on marketing, and not the network itself, is no-win situation. Eventually, a situation like the latter, is a recipe for disaster leading to lack of innovation and a bewildered product. 
COMCAST CORPORATION (CMCSA)
Check out top analysts' recommendation for CMCSA
Last closing price (Feb 12 4:00 EDT):
55.24 (0.44%) ? 
Return to date (1m/3m/6m/12m):
16.56% ? 
Consensus price target (1m/3m/6m/12m):
69.00
 ? 
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Description:
Comcast Corporation operates as a media and technology company worldwide. It operates through Cable Communications, Cable Networks, Broadcast Television, Filmed Entertainment, and Theme Parks segments. The Cable Communications segment offers video, high-speed Internet, and voice services to residential and business customers under the XFINITY brand name. This segment also provides business services, such as cellular backhaul services to mobile network operators; Ethernet network services; and online advertising services. As of December 31, 2012, it served 22.0 million video customers, 19.4 million high-speed Internet customers, and 10.0 million voice customers. The Cable Networks segment consists of national cable entertainment, national cable news and information, national cable sports, regional sports and news, and international cable networks; and a cable television production studio and digital media properties. The Broadcast Television segment comprises NBC and Telemundo broadcast networks, NBC and Telemundo owned local broadcast television stations, broadcast television production operations, and related digital media properties. The Filmed Entertainment segment produces, acquires, markets, and distributes filmed entertainment under the Universal Pictures, Focus Features, and Illumination names. This segment also develops, produces, and licenses stage plays. The Theme Parks segment comprises theme parks; studios; and a dining, retail, and entertainment complex. Comcast Corporation also owns a multipurpose arena in Philadelphia. The company offers its services directly to residential and business customers through call centers; door-to-door selling; direct mail, television, Internet, and local media advertising; and telemarketing and retail outlets. Comcast Corporation was founded in 1963 and is headquartered in Philadelphia, Pennsylvania. (collapse)
Sector:

Industry:
Analyst?Research Firm?Signal?Signal Date?Initial Price?Price Target?Closing Date?Return?
Timothy HoranOppenheimer & Co.Buy  Jan 30, '14  54.19 58.00 Jan 30, '15 1.94% 
Bryan KraftEvercore PartnersBuy  Jan 28, '14  53.35 Jan 28, '15 3.54% 
Douglas MitchelsonDeutsche Bank SecuritiesBuy  Jan 21, '14  53.31 64.00 Jan 21, '15 3.62% 
Thomas EaganCanaccord GenuityBuy  Dec 04, '13  48.88 Dec 04, '14 13.01% 
New York ElitesUnaffiliatedBuy  Nov 13, '13  47.39 52.00 Nov 13, '14 16.56% 
Douglas MitchelsonDeutsche Bank SecuritiesBuy  Oct 29, '13  47.71 60.00 Oct 29, '14 15.78% 
Matthew HarriganWunderlich Securities, Inc.Buy  Oct 28, '13  48.23 63.00 Oct 28, '14 14.53% 
Timothy HoranOppenheimer & Co.Buy  Aug 02, '13  45.52 52.00 Aug 02, '14 21.35% 
Todd MitchellBrean Murray, Carret & Co.Buy  Aug 01, '13  45.64 Aug 01, '14 21.03% 
Tuna AmobiS&P CapitalBuy  Jul 31, '13  44.88 Jul 31, '14 23.08% 
John TinkerMaxim GroupBuy  Jul 31, '13  44.88 56.00 Jul 31, '14 23.08% 
Matthew HarriganWunderlich Securities, Inc.Buy  Jul 05, '13  41.52 56.00 Jul 05, '14 33.04% 
Frank LouthanRaymond JamesBuy  Jun 17, '13  39.72 Jun 17, '14 39.07% 
Timothy HoranOppenheimer & Co.Buy  May 05, '13  42.39 48.00 May 05, '14 30.31% 
Mike MccormackNomuraBuy  May 01, '13  41.48 May 01, '14 33.17% 
Bryan KraftEvercore PartnersBuy  May 01, '13  41.48 May 01, '14 33.17% 
Chris WattsAtlantic EquitiesBuy  Feb 18, '13  40.89 48.00 Feb 18, '14 35.09% 
Bryan KraftEvercore PartnersBuy  Feb 14, '13  39.79 46.00 Feb 14, '14 38.83% 
Jonathan AtkinRBC Capital MarketsBuy  Feb 13, '13  39.58 46.00 Feb 13, '14 39.57% 
Christopher KingStifel Nicolaus & Company, Inc.Buy  Feb 13, '13  39.58 45.00 Feb 13, '14 39.57%





  • Tuesday, January 28, 2014

    Buy stock quote BLRX, at $2.86 with a $5, 8 month target, BioLineRx Ltd. BioLineRx Ltd. has license agreements with Genoscience; Compugen Ltd.; RFS Pharma; Yissum and University of Genoa, Italy; Gestion Univalor, Limited Partnership; and Ikaria. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

    bIOLINERX, LTD. (BLRX)

    Check out top analysts' recommendation for BLRX
    Last closing price (Jan 27 4:00 EDT):
    2.86 (-4.35%) ? 
    Return to date (1m/3m/6m/12m):
    4.00% ? 
    Consensus price target (1m/3m/6m/12m):
    N/A
     ? 
    Buy/Sell Mix (1m/3m/6m/12m):
    N/A
     ? 
    Description:
    BioLineRx Ltd., a clinical stage biopharmaceutical development company, engages in identifying, in-licensing, and developing therapeutic candidates. The company’s development pipeline consists of six clinical-stage therapeutic candidates, including BL-1020, which is in Phase II/III clarity trial to enhance cognitive function in schizophrenia patients; BL-1040, a novel polymer solution that is under pivotal CE-Mark registration trial for use in the prevention of pathological cardiac remodeling following a myocardial infarction; and BL-5010, a medical device, which has completed Phase I/II clinical trials for the non-surgical removal of skin lesions. Its development pipeline also includes BL-1021 that is in Phase Ia clinical trial for the treatment of neuropathic pain, or pain that results from damage to nerve fibers; BL-7040, which is in Phase II clinical trial for the treatment of inflammatory bowel disease; and BL-8040, a peptide that has completed Phase I/II clinical trial for the treatment of acute myeloid leukemia and other hematological cancers. The company also has six products in various pre-clinical development stages for indications, such as central nervous system diseases, infectious diseases, cardiovascular, and autoimmune diseases. In addition, it operates a biotechnology incubator to evaluate therapeutic candidates BioLineRx Ltd. has license agreements with Genoscience; Compugen Ltd.; RFS Pharma; Yissum and University of Genoa, Italy; Gestion Univalor, Limited Partnership; and Ikaria. The company was founded in 2003 and is headquartered in Jerusalem, Israel. (collapse)
    Sector:
    N/A
    Industry:
    N/A
    Analyst?Research Firm?Signal?Signal Date?Initial Price?Price Target?Closing Date?Return?
    Charles GrahamUnaffiliatedBuy  Oct 05, '13  2.66 5.00 Oct 05, '14 7.52% 
    Mesut DoganUnaffiliatedBuy  Sep 20, '13  2.25 5.00 Mar 20, '14 27.11% 
    Ram SelvarajuAegis CapitalBuy  Sep 09, '13  2.30 Sep 09, '14 24.35% 

    JANUARY 28th 2014, HIGHLIGHTING KEY POINTS FOR BARACK OBAMA TO TAKE NOTE OF REGARDING HIS 2014 UNION ADRESS..

             DESPITE ALL THE OBAMA SCANDALS I STILL FORGIVE THE MAN, AND I CAN FORGET, SO LET'S JUST TRY TO MOVE FORWARD TOGETHER, AS A WHOLE. FOR ONCE IT WOULD BE NICE TO HAVE THE PUBLIC AND PRIVATE SECTOR COMMUNICATE WITH EACH OTHER TO PREVENT MISUNDERSTANDS BETWEEN SECTORS OF THE ECONOMY. I AM SO SICK AND TIRED OF SEEING GOVERNMENT ATTACK THE PRIVATE SECTOR. YOU MUST UNDERSTAND THE OBVIOUS, ALL COUNTRIES, ESPECIALLY US, BENEFIT FROM THE ECONOMICAL PERFECTION OF OUR UNIQUE, CAPITALIST SYSTEM, THAT WE INVENTED, MIND YOU. SO, IT'S VERY IMPORTANT THAT WE REMEMBER WHAT GEORGE WASHINGTON AND THOMAS JEFFERSON, JAMES MADISON AND BEN FRANKLIN STAND FOR. THEY AND WE STAND FOR THE EQUALITY OF ALL MAN KIND, AND WE LIKE TO TEACH ALL SOVEREIGN NATIONS HOW TO BE FREE . ALL IT TAKES IS UNDERSTANDING HUMAN RIGHTS, HAVING A DETERMINED SPIRIT, A BRIGHT AND OPEN INTELLIGENT MIND, AND MORE IMPORTANTLY THE WILL TO WORK HARD AND DO THE RIGHT THING. AMERICANS ARE HAPPY AND FREE SPIRITED BECAUSE, BELIEVE IT,OR NOT, AS MUCH AS AMERICANS MAY SEEM TO HATE EACH OTHER, AND, DESPITE THE SO CALLED " MELTING POT," AND ALL THE LOBBYING IN D.C., THE TRUTH IS, WE ALL REALLY CARE ABOUT EACH OTHER, AND THINGS CLICK IN THE U.S. BECAUSE WE HAVE RULES , AND WE ENFORCE THESE RULES. I KNOW SOMETIMES YOU MAY GET MAD AT THE OFFICERS OF THE LAW, BUT THE WHOLE PURPOSE FOR US IN BEING SO STRICT IS SO THAT WE HELP ALL PEOPLE, OR PERSONS, MATURE AND GROW UP, AND FINALLY BECOME MEN AND/OR WOMEN. SO THE BOTTOM LINE IS, IT ALL STARTS WITH OUR CONSTITUTION AND PROTECTING IT, WITHOUT IT THE WHOLE WORLD IS LOST, AND SO WE MUST ALL STAND UP TOGETHER AS ONE NATION, AND ONE WORLD, UNDER GOD, TO PROTECT IT! THANK YOU.

    Monday, December 9, 2013

    Ahead Of The Pack_Camtek (CAMT) Cutting Edge 3D Technology Leads To New Multi Million Dollar Contract With Apple Inc. (AAPL) For Production Of Printed Circuit Boards For Commercial Applications Predicts Investorwand. I gave apple Apple an outperform rating, with a $625 dollar 12 month price target, on December 4th,2013, APPLE IS BACK!!!

    Ahead Of The Pack_Camtek (CAMT) Cutting Edge 3D Technology Leads To New Multi Million Dollar Contract With Apple Inc. (AAPL) For Production Of Printed Circuit Boards For Commercial Applications Predicts Investorwand.
    INvestorwands' leads indicate that Apple may have beaten Intel (INTC) amongst others to the punch by receiving some exclusive rights to Camtek’s proprietary functional 3D printing technology. Shares of Camtek surged over 72% today and then continued higher in after hours trading. Investorwand's network advices that the agreement is still unfinished but is advancing, official word is likely to come in late December or early in the New Year. http://www.investorwand.com/recommendations/viewcompany/5034
    I have a 12 month $625 target as you can below.

    Analyst?Research Firm?Signal?Signal Date?Initial Price?Price Target?Closing Date?Return?
    Brian MarshallISI GroupBuy  Dec 06, '13  560.02 Dec 06, '14 0.00% 
    Gene MunsterPiper JaffrayBuy  Dec 04, '13  565.00 Dec 04, '14 -0.88% 
    Charles GrahamUnaffiliatedBuy  Dec 04, '13  565.00 625.00 Jan 04, '14 -0.88% 
    Heath TerryGoldman SachsBuy  Dec 03, '13  566.32 Dec 03, '14 -1.11% 
    Trip ChowdhryGlobal EquitiesBuy  Dec 02, '13  551.23 Dec 02, '14 1.59% 
    Keith BachmanBMO Capital MarketsBuy  Nov 11, '13  519.05 585.00 Nov 11, '14 7.89% 
    Hans MosesmannRaymond JamesBuy  Oct 30, '13  521.85 650.00 Oct 30, '14 7.31% 

    VanillaSPilla opens 7th Seal...NOSTRADAMUS COMET HITS RUSSIA ~~!! Twin-c VanillaSPilla Oct 2013 !MTV news! FOX NEW"My Tao, A POW, & a THUD...

    Sunday, December 8, 2013

    Ed Tyll Radio Show :ft.Twin c Vanilla Spilla , Beghazi, 9 11 Tribute AIRED ON RADIO, Live Broadcast song, Free Download Ed Tyll Radio Show :ft.Twin c Vanilla Spilla , Beghazi, 9 11 Tribute AIRED ON RADIO, Live Broadcast MP3 and listen to Ed Tyll Radio Show :ft.Twin c Vanilla Spilla , Beghazi, 9 11 Tribute AIRED ON RADIO, Live Broadcast Music online at SongFinder.org


    Ed Tyll Radio Show :ft.Twin c Vanilla Spilla , Beghazi, 9 11 Tribute AIRED ON RADIO, Live Broadcast songFree Download Ed Tyll Radio Show :ft.Twin c Vanilla Spilla , Beghazi, 9 11 Tribute AIRED ON RADIO, Live Broadcast MP3 and listen to Ed Tyll RadioShow :ft.Twin c Vanilla Spilla , Beghazi, 9 11 Tribute AIRED ON RADIO, Live Broadcast Music online at SongFinder.org

    Friday, December 6, 2013

    Geron Corporation (GERN): President and CEO John A. Scarlett Bought 50,000 Shares GERON OWNS MOST OF THE KEY STEM CELL PATENTS THAT EXIST. THEY ARE THE WORLDS LEADING STEM CELL BIOTECH COMPANY, AND ANYONE WHO KNOWS HOW ALL GREAT BIOTECH COMPANIES GET STARTED KNOWS THAT THEY OPERATE WITH DEFICITS UNTIL THEIR FIRST PRODUCT GETS TO MARKET. COMPANIES LIKE AMGEN, GILEAD, DANDREON, ETC ALL BEGAN SAME AS GERON. YOU ARE OBVIOUSLY AND SADLY IGNORANT If you CHOOSE TO ATTACK THE LEADING COMPANY OF WHAT IS FAST BECOMING THE WORLD'S FUTUIRE IN HEALTHCARE SCIENCE, STEM CELLS.

    Geron Corporation (GERN): President and CEO John A. Scarlett Bought 50,000 Shares



    GERON OWNS MOST OF THE KEY STEM CELL PATENTS THAT EXIST. THEY ARE THE WORLDS LEADING STEM CELL BIOTECH COMPANY, AND ANYONE WHO KNOWS HOW ALL GREAT BIOTECH COMPANIES GET STARTED KNOWS THAT THEY OPERATE WITH DEFICITS UNTIL THEIR FIRST PRODUCT GETS TO MARKET. COMPANIES LIKE AMGEN, GILEAD, DANDREON, ETC ALL BEGAN SAME AS GERON. YOU ARE OBVIOUSLY AND SADLY IGNORANT OF THE PROCESS, AND CHOOSE TO ATTACK THE LEADING COMPANY OF WHAT IS FAST BECOMING THE WORLD'S FUTUIRE IN HEALTHCARE SCIENCE, STEM CELLS.




    President and CEO of Geron Corporation (GERN) John A. Scarlett bought 50,000 shares on April 1, 2013 at an average price of $1.10. Geron Corporation was incorporated in Delaware on Nov. 28, 1990. Geron Corporation has a market cap of $143.632 million; its shares were traded at around $1.10.

    Geron Corp. recently reported its fourth quarter 2012 financial results. Net loss for the fourth quarter of 2012 was $15.9 million or $0.12 per share, compared to $31.9 million or $0.25 per share, for the comparable 2011 period.

    Jean-Marie Eveillard owns 1,760,934 shares as of Dec. 31, 2012, which accounts for 0.0088% of the $28.07 billion portfolio of First Eagle Investment Management, LLC.

    Senior Vice President Alliance and Program Management Melissa Kelly Behrs sold 28,292 shares of GERN stock on Jan.17, 2013 at the average price of $1.65. The price of the stock has decreased by 33.33% since.

    Gore's National Security Advisor Was A Russian Spy?! What Does He Know About the Masseuse?

    This week we are going to examine the headline data we all see and then take a look for what most observers do not see. Then we'll try to think about what it all really means. With employment, housing, and the ISM numbers, there is a lot to cover. And this letter will print out longer than usual, as there are a lot of charts. Warning: sharp objects from the vicinity and pour yourself your favorite adult beverage. This does not make for fun reading. But first, a very quick three-paragraph commercial.


    • 3. The initial unemployment claims 4-week moving average stubbornly refuses to go down any further. It has essentially gone sidewa If you go back and look at the data from the last 45 years, the current level is typical of recessions. Earnings Take a Hit No, not business earnings, which seem to be holding up, but personal earnings. Average hourly earnings dropped 0.1% in June, s Rosenberg notes is a 1-in-50 event. The trend is downward, with annual growth of less than 1.7%. Average hours worked were als My friend and Maine fishing buddy Bill Dunkelberg, chief economist at the National Federation of Independent Businesses, has pro survey, and there was not much to cheer about from a future employment perspective. Over the next 3 months, 8 percent of the b plan to reduce employment (up 1 point), and 10 percent plan to create new jobs (down 4 points), yielding a planning to create new jobs, unchanged from May and only the second positive reading in 20 months - but barely so.
    • 4. From Dunk's email: "Since January, 2008, the seasonally adjusted average change in employment per firm has been negative in e seasonally adjusted loss of 0.3 workers per firm reported in June for the prior three month period. Most firms did not change empl points from May) increased average employment by 3.4 employees, but 15% (down 5 points) reduced their workforces by an aver creation" still hasn't crossed the 0 line in the small business sector. Government (including health care and education) and manuf activity) has been providing what few jobs are created, weak given the magnitude of employment loss during the recession. And n temporary Census jobs will make the picture look more bleak, although more accurate. A few more every month for 3 years to re-employ 8 million workers who lost their jobs and another 125,000 a month to keep up with population A few more data points from this week, and then let's look at some of the implications. The numbers from the Conference Board su total of people planning to buy a major appliance is at an almost 16-year low. Car sales were low last month, and the survey says t plans to buy a car are down from 6% to 3.7%. In fact, in almost all categories plans to buy were down. Which makes sense, as 17% incomes are decreasing. New home inventory is back up to 8.5 months of supply. As noted above, single-family sales hit an all-time low, as anyone who wan did so in order to get the government incentive. Just as with Cash for Clunkers, all we did was bring buying forward; we did not cre buyers, at least not in any significant numbers. Money Supply Concerns After the explosion in the money supply by the Fed in the depths of the Great Recession, growth in the money supply has gone fla at the fact that M-3 (the broadest measure of money supply) has turned negative for the first time in many decades. Look at the ad base, below.